Comparative Effect of High-Level Versus Low-Level Laser Therapy on Nerve Root Function Among Healthy Young Adults: A Randomized Controlled Trial
NCT ID: NCT07260994
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
58 participants
INTERVENTIONAL
2025-11-24
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participation is entirely voluntary, and you may withdraw from the study at any time without penalty or need for justifications if you choose to do so.
What is the aim of the study? The objective of the current study is to investigate the short-term effect of high-intensity laser therapy (HILT), low-level laser therapy (LLLT), and sham laser on nerve root function among healthy adults.
Type of participants? We are recruiting participants aged 18-30 years of both genders without any musculoskeletal or neurological disorder involving the upper extremities, non-smokers, and if they expressed their wellness to participate in the current study.
What will participants be asked to do? The purpose of this study is to investigate the short-term effect of high-intensity laser therapy, low-level laser therapy, and sham laser on nerve root function among healthy adults.
If you agree to take part:
* First, we will check if you are eligible for the study.
* If you are eligible and give your consent, you will be randomly placed into one of three groups:
1. High-intensity laser therapy group
2. Low-level laser therapy group
3. Sham (placebo) group - in this group, the laser device will look and feel the same, but it will not actually deliver laser treatment.
* If you are in the sham group, you will not receive active laser therapy. This is important for the scientific accuracy of the study, as it allows us to compare the effects of real laser therapy with no treatment. You will not know which group you are in during the study, but you will be informed after your participation is complete.
* You will attend 9 short sessions over 3 weeks (3 sessions per week). Each session will last about 5-10 minutes.
* To measure nerve function before laser application (Step 1):
1. A small gel will be used to place two sensors on your head (these can be removed easily).
2. Three nerves in your arm will be tested using very light, safe electrical pulses delivered through a small hand-held electrode held in place with a strap.
3. This helps us measure how your nerves are working before laser treatment by measuring the peak-to-peak amplitude and latency of N20 point of the brain through analyzing the brain waves.
* Laser or sham application (Step 2):
1. A researcher will apply the laser (or sham) to three spots on your neck.
2. Each spot will receive laser for about 2 minutes.
3. The laser used is safe, does not cause heat, and you will not feel any burning.
* Measuring nerve function again (Step 3):
The same nerve test from step 1 will be repeated to see if there are any changes after the laser application.
* Men do not need to remove any clothing.
* Women who wear a headscarf will be asked to temporarily remove it so the head sensors can be placed. This will be done in a private room by a female researcher only, with doors locked and separators used to ensure complete privacy.
* Male participants will also be attended to by a male researcher in the same respectful and private way.
* It is very important to note that you may be assigned to a group where the laser is not actually turned on (sham group). This is important for the scientific accuracy of the study.
* You will be told which group you were in after the study is completed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of High-intensity Laser Acupuncture on Muscle Performance, Pain and Quality of Life in Low Back Pain
NCT06612918
High-intensity Versus Low-intensity Laser Acupuncture in Chronic, Non-specific Low Back Pain
NCT06280846
Efficacy of High-intensity Laser Acupuncture in Patients With Chronic, Non-specific Low Back Pain
NCT06260631
Effect of Low-level Laser Therapy Versus Shock Wave Therapy on Pain and Function in Patients With Chronic Non-specific Low Back Pain
NCT06487338
Effect of High-power Laser Acupuncture on Fatigue and Proprioception in Low Back Pain
NCT07196709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HILT group
Participants in HILT group will receive laser therapy with a wavelength of 1064 nm, frequency of 25 Hz, output power of 7 W, and energy dose of 120 J/cm\^2, intervention will be delivered through non-contact mode, by using the Zimmer MedizinSysteme device (OptonPro, Germany) to deliver high-intensity laser over C6, C7, and C8 nerve roots as they exit the spinal column.
High-intensity laser therapy
Participants in HILT group will receive laser therapy with a wavelength of 1064 nm, frequency of 25 Hz, output power of 7 W, and energy dose of 120 J/cm\^2, intervention will be delivered through non-contact mode, by using the Zimmer MedizinSysteme device (OptonPro, Germany) to deliver high-intensity laser over C6, C7, and C8 nerve roots as they exit the spinal column.
LLLT group
Participants in LLLT group will receive laser therapy with wavelength of 905nm, frequency of 5 kHz output power of 25mW, and energy dose of 2 J/cm\^2, intervention will be delivered through contact mode, by using the Enraf-Nonius Endolaser device (South Africa) to deliver low-level laser over C6, C7, and C8 nerve roots as the exit the spinal column.
Low-level laser therapy
Participants in LLLT group will receive laser therapy with wavelength of 905nm, frequency of 5 kHz output power of 25mW, and energy dose of 2 J/cm\^2, intervention will be delivered through contact mode, by using the Enraf-Nonius Endolaser device (South Africa) to deliver low-level laser over C6, C7, and C8 as they exit the spinal column.
Sham laser group
For the participants in the sham group, the same procedure will be followed, but with having the laser device turned off.
Sham laser
For the participants in the sham group, the same procedure will be followed, but with having the laser device turned off.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-intensity laser therapy
Participants in HILT group will receive laser therapy with a wavelength of 1064 nm, frequency of 25 Hz, output power of 7 W, and energy dose of 120 J/cm\^2, intervention will be delivered through non-contact mode, by using the Zimmer MedizinSysteme device (OptonPro, Germany) to deliver high-intensity laser over C6, C7, and C8 nerve roots as they exit the spinal column.
Low-level laser therapy
Participants in LLLT group will receive laser therapy with wavelength of 905nm, frequency of 5 kHz output power of 25mW, and energy dose of 2 J/cm\^2, intervention will be delivered through contact mode, by using the Enraf-Nonius Endolaser device (South Africa) to deliver low-level laser over C6, C7, and C8 as they exit the spinal column.
Sham laser
For the participants in the sham group, the same procedure will be followed, but with having the laser device turned off.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sharjah
OTHER
Taif A. M. Omran
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taif A. M. Omran
Master Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Taif Omran
Role: PRINCIPAL_INVESTIGATOR
University of Sharjah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Sharjah
Sharjah city, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-25-06-24-03-PG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.